New nasal spray trial aims to ease hidden emotional struggles in rare hormone disorder
NCT ID NCT06036004
Summary
This study is testing whether an oxytocin nasal spray can help reduce anxiety and improve social and emotional functioning in adults with central diabetes insipidus. Participants will receive either the oxytocin spray or a placebo spray for two weeks while continuing their standard hormone treatment. The main goal is to see if the spray improves anxiety levels and the ability to recognize emotions in others.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL DIABETES INSIPIDUS (CDI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erasmus University Medical Center Rotterdam
NOT_YET_RECRUITINGRotterdam, 3015, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Basel, Department of Endocrinology, Diabetes & Metabolism
RECRUITINGBasel, 4031, Switzerland
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.